Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The research identified genes and pathways important for sheep wool growth and shedding.

Hair is important for protection, social interaction, and temperature control, and is made of a growth cycle-influenced follicle and a complex shaft.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Cathepsin L is essential for normal hair growth and development.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Thyroid problems can cause hair loss and change hair texture.

Alopecia areata incognita causes widespread hair loss without patches and needs a scalp biopsy for diagnosis.

Kenogen increases with hair loss in women.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Some children are born with unusually short, fine hair because their hair growth phase is short, but this often gets better by itself during puberty.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

The supplement significantly improves hair density and appearance in people with hair loss.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Anorexia nervosa can cause skin problems, which may help with early diagnosis and usually improve with treatment.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.